荷爾蒙補充療法(HRT) 市場規模、佔有率和成長分析：按治療方法、給藥途徑、適應症、分銷管道和地區分類－2026-2033 年產業預測

2024 年全球荷爾蒙補充療法(HRT) 市值為 312.3 億美元，預計到 2033 年將成長至 614 億美元，而 2025 年為 336.7 億美元，預測期（2026-2033 年）的複合年成長率為 7.8%。

全球荷爾蒙補充療法市場正經歷強勁成長，這主要得益於其長期以來在緩解更年期症狀（如潮熱）和降低女性骨質疏鬆風險方面的顯著療效。此外，包括甲狀腺疾病和生長遲緩在內的各種荷爾蒙相關疾病（影響男性和女性）發病率的上升也促進了市場擴張。長效人體生長荷爾蒙（hGH）產品的推出以及這些疾病盛行率的不斷上升進一步推動了市場成長。預計相當一部分人一生中都會面臨甲狀腺問題，凸顯了該市場的巨大潛力。此外，研究表明，荷爾蒙替代療法可能降低新冠肺炎重症的風險，從而增強了其對患者和醫療專業人員的吸引力。

全球荷爾蒙補充療法（HRT）市場的成長要素

全球荷爾蒙補充療法(HRT) 市場的發展動力源自於各類病患小組對有效治療方法的迫切需求，這些患者族群包括生長激素缺乏症、更年期症狀、老齡化性腺功能減退症及其他疾病患者。 HRT治療方法的多樣性體現在其多種給藥途徑上，包括皮膚貼片、口腔黏膜給藥、注射和藥片。隨著全球消費量的成長，生產商正致力於開發先進的給藥系統，例如經皮雌激素貼片和陰道雌激素片。此外，日益成長的安全性擔憂也推動了低劑量雌激素療法的研發，以降低風險，同時凝膠製劑的研發也旨在增強雌激素貼片和其他 HRT 產品的療效。

全球荷爾蒙補充療法（HRT）市場的限制因素

多種因素正在阻礙全球荷爾蒙補充療法(HRT) 市場的成長。儘管治療劑型的多樣性，包括貼片、凝膠、膠囊和注射劑，為患者提供了選擇，但也帶來了一些挑戰。人們對這些療法潛在副作用的擔憂，例如膽固醇升高、血栓、腹脹和水腫，可能會使一些人放棄尋求 HRT 治療。這些副作用會給患者和醫護人員帶來焦慮，可能限制市場擴張和荷爾蒙補充療法的普及，最終影響整個產業的成長潛力。

全球荷爾蒙補充療法（HRT）市場趨勢

全球荷爾蒙補充療法(HRT) 市場正經歷著蓬勃發展的趨勢，這主要得益於人們對荷爾蒙相關健康問題的日益關注以及尚未滿足的巨大需求，尤其是在新興市場。在主要地區更年期和荷爾蒙缺乏相關疾病盛行率不斷上升的背景下，製藥公司正日益專注於創新和推出先進治療方法以滿足這一需求。這種情況正在推動人們逐漸拋棄傳統的每日長效注射藥物，並加速新型聯合治療的研發。隨著消費者和醫療專業人員知識的不斷加深，預計該市場將顯著成長，反映出人們正朝著個人化和高效的荷爾蒙管理解決方案轉變。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價格分析
• 案例研究
• 技術分析
• 專利分析

全球荷爾蒙補充療法（HRT）市場規模：依治療方法分類

• 雌激素替代療法
• 黃體素替代療法
• 聯合荷爾蒙療法
• 睾酮替代療法
• 其他

全球荷爾蒙補充療法（HRT）市場規模：依給藥途徑分類

• 口服
• 經皮
• 注射藥物
• 陰道
• 其他

全球荷爾蒙補充療法(HRT) 市場規模：依適應症分類

• 停經
• 性腺功能減退
• 甲狀腺疾病
• 生長激素缺乏症
• 性別重置療法
• 其他

全球荷爾蒙補充療法(HRT) 市場規模：按分銷管道分類

• 醫院藥房
• 零售藥房
• 網路藥房
• 其他

全球荷爾蒙補充療法（HRT）市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Pfizer Inc.
• Novartis AG
• AbbVie Inc.
• Bayer AG
• Merck KGaA
• Theramex Group Limited
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Viatris Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Sanofi SA
• Endo International plc
• Amneal Pharmaceuticals, Inc.
• Apotex Inc.
• Aspen Pharmacare Holdings Limited
• Organon & Co.
• Dr. Reddy's Laboratories Limited
• Sun Pharmaceutical Industries Limited

結論與建議

Global Hormone Replacement Therapy (HRT) Market size was valued at USD 31.23 Billion in 2024 and is poised to grow from USD 33.67 Billion in 2025 to USD 61.4 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global hormone replacement therapy market is experiencing robust growth driven by its long-standing effectiveness in alleviating menopause-related symptoms such as hot flashes and osteoporosis risks in women. Additionally, the rising incidence of various hormone-related conditions, including thyroid disorders and growth deficiencies affecting both genders, is contributing to market expansion. The introduction of long-acting human growth hormone (hGH) products and the increasing prevalence of target diseases further propel this growth. It is projected that a significant portion of the population will encounter thyroid issues during their lifetimes, highlighting the market's potential. Furthermore, research indicates that HRT may lower the risk of severe COVID-19 outcomes, enhancing its appeal among patients and healthcare providers alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (HRT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hormone Replacement Therapy (HRT) Market Segments Analysis

Global Hormone Replacement Therapy (HRT) Market is segmented by Therapy Type, Route of Administration, Indication, Distribution Channel and region. Based on Therapy Type, the market is segmented into Estrogen Replacement Therapy, Progesterone Replacement Therapy, Combination Hormone Therapy, Testosterone Replacement Therapy and Others. Based on Route of Administration, the market is segmented into Oral, Transdermal, Injectable, Vaginal and Others. Based on Indication, the market is segmented into Menopause, Hypogonadism, Thyroid Disorders, Growth Hormone Deficiency, Gender Transition Therapy and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hormone Replacement Therapy (HRT) Market

The Global Hormone Replacement Therapy (HRT) market is driven by the critical need for effective treatments among diverse patient groups, including those experiencing growth hormone deficiencies, menopausal symptoms, and age-related hypogonadism. A range of administration methods-including skin patches, buccal delivery, injections, and tablets-highlights the versatility of these therapies. As global consumption rises, manufacturers are innovating with advanced drug delivery systems such as transdermal estrogen patches and vaginal estrogen tablets. Additionally, there is a growing focus on safety, leading to the development of low-dose estrogen therapies to mitigate risks, along with gel-based formulations that enhance the effectiveness of estrogen patches and other HRT products.

Restraints in the Global Hormone Replacement Therapy (HRT) Market

Several factors are hindering the growth of the Global Hormone Replacement Therapy (HRT) market. The wide variety of treatment formulations, including patches, gels, capsules, and injections, offers options to patients but may also pose challenges. Concerns about potential side effects associated with these therapies, such as elevated cholesterol levels, blood clots, bloating, and swelling, can deter individuals from pursuing HRT. These adverse reactions create apprehension among patients and healthcare providers alike, which can limit market expansion and adoption of hormone replacement therapies, ultimately impacting the overall growth potential of the industry.

Market Trends of the Global Hormone Replacement Therapy (HRT) Market

The Global Hormone Replacement Therapy (HRT) market is witnessing a dynamic trend propelled by rising awareness of hormone-related health issues and significant unmet demand, particularly in emerging economies. Pharmaceutical companies are increasingly focused on innovating and introducing advanced therapies to address this demand, spurred by the prevalence of menopause and hormone deficiency-related conditions in key regions. This landscape has encouraged the development of novel combination treatment products, moving away from traditional daily long-acting parenteral medications. As consumers and healthcare providers become more informed, the market is poised for substantial growth, reflecting a shift towards personalized and effective hormone management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Pricing Analysis
• Case Studies
• Technology Analysis
• Patent Analysis

Global Hormone Replacement Therapy (HRT) Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• Estrogen Replacement Therapy
• Progesterone Replacement Therapy
• Combination Hormone Therapy
• Testosterone Replacement Therapy
• Others

Global Hormone Replacement Therapy (HRT) Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Transdermal
• Injectable
• Vaginal
• Others

Global Hormone Replacement Therapy (HRT) Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Menopause
• Hypogonadism
• Thyroid Disorders
• Growth Hormone Deficiency
• Gender Transition Therapy
• Others

Global Hormone Replacement Therapy (HRT) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Hormone Replacement Therapy (HRT) Market Size & CAGR (2026-2033)

• North America (Therapy Type, Route of Administration, Indication, Distribution Channel)
  • US
  • Canada
• Europe (Therapy Type, Route of Administration, Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapy Type, Route of Administration, Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapy Type, Route of Administration, Indication, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapy Type, Route of Administration, Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theramex Group Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspen Pharmacare Holdings Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations